IL142269A0 - Process for recovering heterologous polypetides from bacterial cells - Google Patents

Process for recovering heterologous polypetides from bacterial cells

Info

Publication number
IL142269A0
IL142269A0 IL14226999A IL14226999A IL142269A0 IL 142269 A0 IL142269 A0 IL 142269A0 IL 14226999 A IL14226999 A IL 14226999A IL 14226999 A IL14226999 A IL 14226999A IL 142269 A0 IL142269 A0 IL 142269A0
Authority
IL
Israel
Prior art keywords
nucleic acid
bacterial cells
recovering
acid encoding
polypetides
Prior art date
Application number
IL14226999A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL142269A0 publication Critical patent/IL142269A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14226999A 1998-10-28 1999-10-21 Process for recovering heterologous polypetides from bacterial cells IL142269A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10605298P 1998-10-28 1998-10-28
PCT/US1999/024696 WO2000024873A1 (en) 1998-10-28 1999-10-21 Process for recovering heterologous polypeptides from bacterial cells

Publications (1)

Publication Number Publication Date
IL142269A0 true IL142269A0 (en) 2002-03-10

Family

ID=22309219

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14226999A IL142269A0 (en) 1998-10-28 1999-10-21 Process for recovering heterologous polypetides from bacterial cells
IL142269A IL142269A (en) 1998-10-28 2001-03-27 Process for recovering heterologous polypeptides from bacterial cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142269A IL142269A (en) 1998-10-28 2001-03-27 Process for recovering heterologous polypeptides from bacterial cells

Country Status (13)

Country Link
US (2) US6180367B1 (de)
EP (2) EP1124941B1 (de)
JP (1) JP3711326B2 (de)
AT (2) ATE415469T1 (de)
AU (1) AU752429B2 (de)
CA (1) CA2346797C (de)
CY (1) CY1109847T1 (de)
DE (2) DE69939991D1 (de)
DK (2) DK1323820T3 (de)
ES (2) ES2207340T3 (de)
IL (2) IL142269A0 (de)
PT (2) PT1124941E (de)
WO (1) WO2000024873A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386102T1 (de) * 1998-03-30 2008-03-15 Metabolix Inc Mikrobielle stämme und verfahren für die herstellung von biomaterialien
WO2000024769A2 (en) 1998-10-28 2000-05-04 Genentech, Inc. Process for recovering heterologous polypeptide from bacterial refractile particles
AU4305501A (en) * 1999-12-30 2001-07-16 Intel Corporation Optimized driver layout for integrated circuits with staggered bond pads
US6784558B2 (en) * 1999-12-30 2004-08-31 Intel Corporation Semiconductor device inlcluding optimized driver layout for integrated circuit with staggered bond pads
KR100968664B1 (ko) 2001-08-27 2010-07-06 제넨테크, 인크. 항체 발현 및 조립을 위한 시스템
US20030198682A1 (en) * 2002-02-12 2003-10-23 Gruber James V. Composition and method for protecting labile active components during high temperature drying
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US7195611B1 (en) 2002-12-31 2007-03-27 Advanced Cardiovascular Systems, Inc. Rapid exchange balloon catheter having a reinforced inner tubular member
WO2004081033A2 (en) * 2003-03-11 2004-09-23 National Institutes Of Health Synthesis of proteins by cell-free protein expression
AU2004317306B2 (en) 2003-11-21 2010-09-02 Pelican Technology Holdings, Inc. Improved expression systems with Sec-system secretion
US8603824B2 (en) 2004-07-26 2013-12-10 Pfenex, Inc. Process for improved protein expression by strain engineering
CA2577419A1 (en) * 2004-08-16 2006-03-09 Nature Technology Corp. Improved strains of e. coli for plasmid dna production
US20060156998A1 (en) * 2005-01-19 2006-07-20 Shawn Bridy Protective collar for animals
NZ568809A (en) 2005-12-22 2011-08-26 Genentech Inc Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents
US20080125580A1 (en) 2006-07-14 2008-05-29 Genentech, Inc. Refolding of Recombinant Proteins
CN103540562A (zh) * 2006-11-30 2014-01-29 诺维信公司 重组宿主细胞中的脱氧核糖核酸酶表达
JP5714230B2 (ja) 2007-01-31 2015-05-07 フェネックス インコーポレイテッド 発現上昇のための細菌リーダー配列
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
JP5444553B2 (ja) 2007-04-27 2014-03-19 フェネックス インコーポレイテッド 微生物宿主を迅速にスクリーニングして、異種タンパク質発現の収率および／または質が改善されている特定の株を同定する方法
US9017966B2 (en) 2007-05-23 2015-04-28 Nature Technology Corporation E. coli plasmid DNA production
EP2285965A1 (de) * 2008-03-31 2011-02-23 Pfenex Inc Ansatz zur schnellen klonierung einer oder mehrerer polypeptidketten in ein expressionssystem
ES2370947B1 (es) * 2009-12-23 2012-11-02 Consejo Superior De Investigaciones Científicas (Csic) Sistema de autolisis celular para el procesado de la biomasa bacteriana en la produccion de polihidroxialcanoatos en pseudomonas putida kt2440
KR101222889B1 (ko) 2010-02-25 2013-01-17 고려대학교 산학협력단 이중프로모터를 포함하는 발현 시스템 및 그 시스템을 이용한 유전자 과다 발현 방법
WO2013147043A1 (ja) * 2012-03-29 2013-10-03 株式会社シノテスト 核酸の検出又は定量方法及び検出又は定量用試薬キット
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
ES2853935T3 (es) 2013-03-12 2021-09-20 Massachusetts Gen Hospital Proteínas modificadas de sustancia inhibidora muleriana (MIS) y usos de las mismas para el tratamiento de enfermedades
US11135269B2 (en) 2013-12-11 2021-10-05 The General Hospital Corporation Use of mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation
EP3186379B1 (de) 2014-08-28 2020-04-08 Synthetic Biologics, Inc. Auf e. coli basierende herstellung von beta-lactamase
SG11201808562SA (en) * 2016-03-29 2018-10-30 Geltor Inc Expression of proteins in gram-negative bacteria wherein the ratio of periplasmic volume to cytoplasmic volume is between 0.5:1 and 10:1
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
GB201814590D0 (en) * 2018-09-07 2018-10-24 Oxford Biomedica Ltd Viral vector production system
JP2022024197A (ja) * 2018-09-28 2022-02-09 Ｓｐｉｂｅｒ株式会社 組換え細胞、組換え細胞の破砕方法及び目的タンパク質の製造方法
KR20210151930A (ko) 2019-04-12 2021-12-14 젤터, 인코포레이티드 재조합 엘라스틴 및 이의 제조
KR102718712B1 (ko) * 2019-08-05 2024-10-17 와커 헤미 아게 발효 방법에서 재조합 단백질 방출용 박테리아 균주
EP4127205A1 (de) * 2020-04-03 2023-02-08 Novozymes A/S Untergetauchtes fermentationsverfahren
EP3926039A1 (de) * 2020-06-17 2021-12-22 AB Enzymes GmbH Verwendung einer nuklease zur verringerung der viskosität und/oder zur verhinderung eines viskositätsanstiegs einer fermentationsbrühe
US20240352432A1 (en) * 2021-08-11 2024-10-24 Duke University Rapid expression and purification of thermostable proteins including taq polymerase
EP4638773A1 (de) * 2022-12-23 2025-10-29 Thermo Fisher Scientific Baltics Uab Geschlossenes system zur expression rekombinanter proteine unter verwendung von e. coli und verfahren zur herstellung geklärter zellkulturen davon
CN118420716B (zh) * 2024-05-28 2025-10-31 青岛农业大学 一种多肽125、包含多肽125的生物材料及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595658A (en) 1982-09-13 1986-06-17 The Rockefeller University Method for facilitating externalization of proteins synthesized in bacteria
US4637980A (en) * 1983-08-09 1987-01-20 Smithkline Beckman Corporation Externalization of products of bacteria
EP0155189A3 (de) 1984-03-16 1987-09-16 Genentech, Inc. Expression eines die Zellwand degradierenden Proteins und für ein solches Protein kodierende DNS enthaltende Wirtszellen
DE3507648A1 (de) 1985-03-05 1986-09-11 Klöckner-Humboldt-Deutz AG, 5000 Köln Vorrichtung und verfahren zum warmhalten von fluessigen metallschmelzen
JPH0640832B2 (ja) 1985-05-10 1994-06-01 味の素株式会社 インタ−ロイキン２ポリペプチドの回収方法
SE8505027D0 (sv) * 1985-10-24 1985-10-24 Kabigen Ab A lytic virulent phage, a hostcell containing same and a process for protein production
US5169772A (en) 1988-06-06 1992-12-08 Massachusetts Institute Of Technology Large scale method for purification of high purity heparinase from flavobacterium heparinum
US5512456A (en) * 1990-05-25 1996-04-30 James Madison University Method for the improved production and recovery of poly-β-hydroxybutyrate from transformed Escherichia coli
RU2071503C1 (ru) 1992-02-18 1997-01-10 Биотехнологическая компания "Биосервис" ВЕКТОР pЕL5С, ПРЕДНАЗНАЧЕННЫЙ ДЛЯ ЭКСПРЕССИИ ЧУЖЕРОДНОЙ ДНК
RU2043415C1 (ru) 1992-02-18 1995-09-10 Биотехнологическая компания "Биосервис" ВЕКТОР PEL 5b, ПРЕДНАЗНАЧЕННЫЙ ДЛЯ ЭКСПРЕССИИ ЧУЖЕРОДНОЙ ДНК
RU2071501C1 (ru) 1992-02-18 1997-01-10 Биотехнологическая компания "Биосервис" Вектор реl25а, предназначенный для экспрессии чужеродного днк
WO1994012214A1 (en) 1992-12-01 1994-06-09 Protein Design Labs, Inc. Humanized antibodies reactive with cd18

Also Published As

Publication number Publication date
CA2346797A1 (en) 2000-05-04
WO2000024873A9 (en) 2000-11-02
JP3711326B2 (ja) 2005-11-02
DE69911450T2 (de) 2004-07-22
ATE415469T1 (de) 2008-12-15
EP1124941A1 (de) 2001-08-22
US6258560B1 (en) 2001-07-10
ATE250125T1 (de) 2003-10-15
DE69911450D1 (de) 2003-10-23
EP1323820A3 (de) 2003-07-09
AU752429B2 (en) 2002-09-19
DK1124941T3 (da) 2004-02-02
EP1323820B1 (de) 2008-11-26
AU1219500A (en) 2000-05-15
IL142269A (en) 2010-12-30
PT1124941E (pt) 2004-02-27
CY1109847T1 (el) 2014-09-10
DE69939991D1 (de) 2009-01-08
US6180367B1 (en) 2001-01-30
PT1323820E (pt) 2009-03-05
ES2318070T3 (es) 2009-05-01
ES2207340T3 (es) 2004-05-16
JP2002528071A (ja) 2002-09-03
EP1323820A2 (de) 2003-07-02
DK1323820T3 (da) 2009-03-16
WO2000024873A1 (en) 2000-05-04
EP1124941B1 (de) 2003-09-17
CA2346797C (en) 2008-09-23

Similar Documents

Publication Publication Date Title
IL142269A0 (en) Process for recovering heterologous polypetides from bacterial cells
CA2342537A1 (en) Modified e. coli enterotoxin ii signal peptide and a microorganism expressing a fusion protein of said peptide and a heterologous protein
CA2203373A1 (en) Process for improved recombinant production of disulphide bond-containing polypeptides via a protein disulfide isomerase
TW201629226A (zh) 用於胜肽生產之融合夥伴
IN190327B (de)
AU7550098A (en) System for expressing hyperthermostable protein
CA2195625A1 (en) Ubiquitin-Lytic Peptide Fusion Gene Constructs, Protein Products Deriving Therefrom, and Methods of Making and Using Same
WO1998021343B1 (en) Genes encoding telomerase proteins
EP2014770A3 (de) WNT-1-induziertes sekretiertes Polypeptid WISP-2
US8765910B2 (en) Method for amidating polypeptides with basic amino acid C-terminals by means of specific endoproteases
CA2066370A1 (en) Yield when disulfide-bonded proteins are secreted
WO1996017941A3 (en) Production of c-terminal amidated peptides from recombinant protein constructs
EP1688430A3 (de) Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäure
EP0794254A3 (de) Verfahren zur Herstellung sekretorischer KEX2-Derivate
EP0953644A4 (de) Systeme zur massenherstellung von proteinen oder peptiden durch mikroorganismen der gattung humicola
AU9086398A (en) G protein chimeras
EP0139501A3 (de) Herstellung und Expression von Genen für Thaumatin
AU7057098A (en) Improved prokaryotic expression of protein
GR3034704T3 (en) Recombinant vector for the exocellular preparation of single chain antibodies expressed in bacillus subtilis.
MIYAKE et al. Secretion of human interferon-α induced by using secretion vectors containing a promoter and signal sequence of alkaline phosphatase gene of Escherichia coli
KR20190027698A (ko) 재조합 단백질의 분비를 증가시키는 방법
Wong et al. Escherichia coli: A versatile platform for recombinant protein expression
Stahl et al. Selection for signal sequence mutations that enhance production of secreted human proinsulin by Escherichia coli
KR970001537A (ko) 재조합인슐린유사성장인자i의개선된생산방법
JPH06253862A (ja) 新規発現ベクタ−、該発現ベクタ−を保有 する微生物、該微生物を用いる有用物質の 製造法